Business Standard

Tuesday, December 24, 2024 | 11:09 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Johnson & Johnson to stop selling talc-based baby powder in US, Canada

J&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs

Johnson & Johnson
Premium

Healthcare products and the talc-based powder will still be sold outside the US and Canada

Agencies
Johnson & Johnson is ending sales of its iconic talc-based Johnson’s baby powder in the US and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer. They said that healthcare products and the talc-based powder will still be sold outside the US and Canada.
 
“Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the company said.
 
J&J faces about 19,400 cases alleging its talcum powder caused

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in